These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 17201870)
1. Do your patients suffer from excessive yawning? Gutiérrez-Alvarez AM Acta Psychiatr Scand; 2007 Jan; 115(1):80-1. PubMed ID: 17201870 [TBL] [Abstract][Full Text] [Related]
2. Yawning as a dose-dependent side effect of treatment with escitalopram. Roncero C; Mezzatesta-Gava M; Grau-López L; Daigre C Neurologia; 2013; 28(9):589-90. PubMed ID: 22795392 [No Abstract] [Full Text] [Related]
3. Attention to side effects enhances medical adherence. Vinberg M Acta Psychiatr Scand; 2007 Jan; 115(1):82. PubMed ID: 17201871 [No Abstract] [Full Text] [Related]
6. Emergence of electric shock-like sensations on escitalopram discontinuation. Prakash O; Dhar V J Clin Psychopharmacol; 2008 Jun; 28(3):359-60. PubMed ID: 18480703 [No Abstract] [Full Text] [Related]
7. Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care. Lepola UM; Loft H; Reines EH Int Clin Psychopharmacol; 2003 Jul; 18(4):211-7. PubMed ID: 12817155 [TBL] [Abstract][Full Text] [Related]
8. Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study. Nierenberg AA; Greist JH; Mallinckrodt CH; Prakash A; Sambunaris A; Tollefson GD; Wohlreich MM Curr Med Res Opin; 2007 Feb; 23(2):401-16. PubMed ID: 17288694 [TBL] [Abstract][Full Text] [Related]
9. [Depressive disorders in panic attack patients and their correction with escitalopram]. Levada OA; Cherednichenko NV Lik Sprava; 2005; (5-6):77-80. PubMed ID: 16396301 [TBL] [Abstract][Full Text] [Related]
10. Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report. McGrath PJ; Khan AY; Trivedi MH; Stewart JW; Morris DW; Wisniewski SR; Miyahara S; Nierenberg AA; Fava M; Rush AJ J Clin Psychiatry; 2008 Dec; 69(12):1847-55. PubMed ID: 19026268 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis. Kennedy SH; Andersen HF; Lam RW J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428 [TBL] [Abstract][Full Text] [Related]
14. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor. Lenox-Smith AJ; Jiang Q Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of agomelatine and escitalopram on depression, subjective sleep and emotional experiences in patients with major depressive disorder: a 24-wk randomized, controlled, double-blind trial. Corruble E; de Bodinat C; Belaïdi C; Goodwin GM; Int J Neuropsychopharmacol; 2013 Nov; 16(10):2219-34. PubMed ID: 23823799 [TBL] [Abstract][Full Text] [Related]
16. Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression. Benazzi F Can J Psychiatry; 2005 Mar; 50(3):184. PubMed ID: 15830829 [No Abstract] [Full Text] [Related]